Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 1,801–1,900 of 3,349
Liu, X., Zhou, Q., Zhang, J.-H., Wang, K., Saito, T., Saido, T. C., Wang, X., Gao, X., & Azuma, K. (2021) · Cells · doi:10.3390/cells10113261 · Cited by 16
Heshmati-Fakhr, N., Sotoodehnejadnematalahi, F., Yousefi, N., Sayyah, M., Hosseini, S. M., & Pourbadie, H. G. (2018) · Neuroreport · doi:10.1097/wnr.0000000000001132 · Cited by 16
Kang, Y., Jefferson, A., Sheehan, A. E., Torre, R. D. L., Jay, T. R., Chiao, L. J., Hulegaard, A. L., Corty, M. M., Baconguis, I., Zhou, Z., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.06.565932 · Cited by 12
An astrocyte-microglia MFG-E8 axis promotes synapse engulfment in early amyloid pathology
Sokolova, D., Puletti, F., Ghansah, S. A., Georgiades, T., Zheng, Y., Wu, L., Schepper, S. D., Lange, J., Ferreira, L. S. S., Sierksma, A., et al. (2026) · Neuron · doi:10.1101/2024.08.31.606944 · Cited by 15
Self-citationMicroglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Zhang, L., Huang, L., Zhou, Y., Meng, J., Zhang, L., Zhou, Y., Zheng, N., Guo, T., Zhao, S., Wang, Z., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00789-7 · Cited by 13
“Excessive elimination of synapses in AD animal models, presumably mediated by a dysregulated complement system, has also been proposed [20–22].”
InfluentialGomez, A. R., Byun, H. R., Wu, S., Muhammad, A. K. M. G., Ikbariyeh, J., Chen, J., Muro, A., Li, L., Bernstein, K. E., Ainsworth, R., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00879-1 · Cited by 13
“Synapses are eliminated, at least in part, through mechanisms that involve labeling them with complement component C1q and targeting them for MG-dependent elimination 43 .”
Aging-induced alterations in microglial cells and their impact on neurodegenerative disorders
Singh, H., Gupta, R., Gupta, M., & Ahmad, A. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10623-y · Cited by 14
“Cognitive decline in AD is found to be associated with abnormal synapse loss [59, 60].”
Not just neurons: The diverse cellular landscape of learning and memory
Alberini, C. M. (2025) · Neuron · doi:10.1016/j.neuron.2025.05.005 · Cited by 17
Zou, Y., Ho, I. H. T., Jiang, Y., Li, Z., Luo, Q., Ng, L. H. L., Jin, T., Li, Q., Qin, F., Tan, L., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adk8096 · Cited by 14
Dysregulation of Immune Mediators and Synaptic Plasticity in Central Nervous System Disorders
Imbriani, P., D’Ambra, C., Mori, R. D., Ionta, M., Renna, A., & Bonsi, P. (2026) · Cells · doi:10.3390/cells15020201 · Cited by 16
Gopalakrishna, P. K., Nassir, C. M. N. C. M., Anandan, S., Hussan, F., Dandala, K. C. R., Sura, S., Jagadeesan, S., Moklas, M. A. M., Vishnumukkala, T., & Hein, Z. M. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01671-4 · Cited by 25
Revi, N., & Rengan, A. K. (2020) · BioNanoScience · doi:10.1007/s12668-020-00789-z · Cited by 11
Qiu, X., Ping, S., Kyle, M. M., Chin, L. S., & Zhao, L. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01160-3 · Cited by 13
“Microglia play an important role in neural circuit remodeling in both healthy and diseased brains by activity-dependent synaptic pruning [32, 62, 76].”
BackgroundZhang, Y., Hu, Y., Han, Z., Geng, Y., Xia, Z., Zhou, Y., Wang, Z., Wang, Y., Kong, E., Wang, X., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220009 · Cited by 12
“Moreover, previous studies have demonstrated that both presynaptic and postsynaptic proteins are fundamental to normal synaptic function and that their downregu-lations are correlated with cognitive deficits in AD [4–6].”
Immunosenescence of brain accelerates Alzheimer’s disease progression
Chen, H.-Y., Zhao, Y. G., & Xie, Y. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0021 · Cited by 12
Excitation-inhibition imbalance disrupts visual familiarity in amyloid and non-pathology conditions
Niraula, S., Doderer, J. J., Indulkar, S. S., Berry, K., Hauser, W. L., L’Esperance, O. J., Deng, J. Z., Keeter, G., Rouse, A. G., & Subramanian, J. (2023) · Cell Reports · doi:10.1016/j.celrep.2022.111946 · Cited by 16
“Decreased PSD95 but normal synaptophysin puncta levels in CA1 have been reported previously.(69) In contrast, reduced synaptophysin levels have also been observed in the samemodel.”
BackgroundMicroRNA-mediated regulation of reactive astrocytes in central nervous system diseases
Fan, Y., Huang, H., Shao, J., & Huang, W. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1061343 · Cited by 14
Kikutani, K., Hosokawa, K., Giga, H., Ota, K., Matsumata, M., Zhu, M., Takemoto, H., Ji, B., Ohshimo, S., Shime, N., et al. (2022) · Shock · doi:10.1097/shk.0000000000002030 · Cited by 14
“Synaptic dysfunction has been implicated in the pathophysiology underlying psychiatric and neurodegenerative disorders with cognitive impairment (27,28).”
BackgroundHuang, Z. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221042 · Cited by 17
“Oligomeric A (cid:2) directly injected into the brain also induces significantly higher volumes of microglial engulfment of synaptic elements than monomeric A (cid:2) [114].”
Shi, G., Zhang, C., Li, G., Wang, K., Cai, Q., & Huang, M. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114583 · Cited by 12
Microglia activation mediates circadian rhythm disruption-induced cognitive impairment in mice
Meng, D., Yang, M., Zhang, H., Zhang, L., Song, H., Liu, Y., Zeng, Y., Yang, B. K., Wang, X., Chen, Y., et al. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578102 · Cited by 15
Lantz, M. J., Roberts, A. M., Delgado, D. D., & Nichols, R. A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02807-9 · Cited by 13
“Oligomeric Aβ has been shown to target synapses [60, 61], which may be later eliminated by microglia in a complement-dependent manner [16].”
BackgroundResultInfluentialTsumagari, K., Sato, Y., Aoyagi, H., Okano, H., & Kuromitsu, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-45570-w · Cited by 18
“Upregulation of complement proteins is tightly associated with neuroinflammatory events and has been observed in various neurodegenerative diseases, including Alzheimer’s disease and related disease models (9, 25, 26).”
Neutrophil-inflicted vasculature damage suppresses immune-mediated optic nerve regeneration
Passino, R., Finneran, M. C., Hafner, H., Feng, Q., Huffman, L. D., Zhao, X., Johnson, C. N., Kawaguchi, R., Osés-Prieto, J. A., Burlingame, A. L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113931 · Cited by 13
Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment
Bäckström, T. C., Doverskog, M., Blackburn, T. P., Scharschmidt, B. F., & Felipo, V. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105668 · Cited by 16
The association between waist-to-height ratio and cognitive function in older adults
Tang, H., Li, Q., & Du, C. (2024) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2339729 · Cited by 12
Melendez, J., Sung, Y. J., Orr, M. E., Yoo, A. S. J., Schindler, S. E., Cruchaga, C., & Bateman, R. J. (2024) · Aging Cell · doi:10.1111/acel.14230 · Cited by 11
“Aberrant overexpression of complement components by microglia has also been linked to Huntington's disease (HD) (Singhrao et al., 1999) and shown to play a role in neurodegeneration and AD in mouse models (Hong et al., 2016).”
BackgroundThe intricate interplay between microglia and adult neurogenesis in Alzheimer’s disease
Früholz, I., & Meyer‐Luehmann, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1456253 · Cited by 18
Sun, H., Gao, X., Niu, J., Chen, P., He, S., Xu, S., & Ge, J. (2024) · eneuro · doi:10.1523/eneuro.0310-24.2024 · Cited by 12
“Inrecent years, growing evidence highlighted the role of microglia and its related neu-roin fl ammation in the pathogenesis and progression of AD (S. Hong et al., 2016; Hansen et al., 2018).”
Xu, R., Chen, H., Wang, Y., Qi, H., Chen, Y., Dai, A., Yang, S., Wang, Y., Zeng, Y., & Li, J. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.136901 · Cited by 13
Neuroinflammation: A Driving Force in the Onset and Progression of Alzheimer’s Disease
Long, C., Fritts, A., Broadway, J., Brawman‐Mintzer, O., & Mintzer, J. E. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020331 · Cited by 22
“A gross influx of activated microglial cells to affected areas has been linked with aberrant synaptic pruning, the increased release of damaging ROS, and increased production of matrix metalloproteinase-3 (MMP-3), which has been shown to degrade the extracellular matrix [8].”
Strackeljan, L., Baidoe‐Ansah, D., Mirzapourdelavar, H., Jia, S., Kaushik, R., Cangalaya, C., & Dityatev, A. E. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115186 · Cited by 14
Refining the interactions between microglia and astrocytes in Alzheimer’s disease pathology
Chen, J., Xu, S., Wang, L., Liu, X., Liu, G., Tan, Q., Li, W., Zhang, S., & Du, Y. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.033 · Cited by 17
Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases
Choi, Y., & Chung, W. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00870-9 · Cited by 16
“Importantly, it has also been shown that the ablation of C1q, C3, or microglial CR3 preserves synapse density and cognitive function, preventing neuronal degeneration and brain atrophy in AD [52–54 , The complement pathway also mediates synapse pruning in other NDs.”
Stowell, R. D., & Wang, K. H. (2025) · Nature Communications · doi:10.1038/s41467-025-63314-4 · Cited by 14
“Microglial immune machinery, such as the complement system, is frequently repurposed for synaptic pruning during health and disease 14,49 .”
2016 yearbook of neurorestoratology
Huang, H., Mao, G., Feng, S., & Chen, L. (2017) · Journal of Neurorestoratology · doi:10.2147/jn.s132589 · Cited by 14
“Further inappropriately activated microglia in adult brains could engulf synaptic material in a CR3-dependent process when exposed to soluble Aβ oligomers, which might be one cause for the induction of synapse loss in Alzheimer’s disease (AD).(19) Major drivers of neurodegeneration may result from complement activatio…”
BackgroundBae, S., Kim, H. W., Shin, S., Kim, J., Jeong, Y., & Moon, J. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0057-6 · Cited by 16
“This result is consistent with a recent report demonstrating that microglia and complement induce and mediate synapse loss in AD and indicating the close association between immune responses and cognitive impairments 18,31 .”
ResultSchram, S., Loeb, J. A., & Song, F. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01849-7 · Cited by 13
Machine learning classifies predictive kinematic features in a mouse model of neurodegeneration
Huang, R., Nikooyan, A. A., Xu, B., Joseph, M. S., Damavandi, H. G., von Trotha, N., Li, L., Bhattarai, A., Zadeh, D., Seo, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82694-3 · Cited by 16
Li, Q., Li, H., Yao, X., Wang, C., Liu, H., Xu, D., Yang, C., Zhuang, H., Xiao, Y. M., Liu, R., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.749925 · Cited by 14
Cortisol and cytokines in schizophrenia: A scoping review
Farcas, A., Christi, P., & Iftene, F. (2023) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2023.100192 · Cited by 14
“Reductions in microglial activity during neurodevelopment may lead to reduced synaptic pruning, and sustained deficits in synaptic connectivity [20], while excessive microglial activity later in life has been linked to synaptic loss and cognitive decline [21].”
BackgroundTREM2: Keeping Microglia Fit during Good Times and Bad
Hong, S. Y., & Stevens, B. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.010 · Cited by 13
“…studies, depleting microglia in AD mouse models has yielded little change in plaque pathology; however, manipulation of microglia or microglial genes suggests an amelioration in synaptic and behavioral outcomes (Hong et al., 2016; Hong and Stevens, 2016; Shi et al., 2017; Spangenberg et al., 2016).”
BackgroundSelf-citationDavies, C., & Spires‐Jones, T. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.12.003 · Cited by 11
“In regard to Litvinchuk et al. (2018), an investigation into how C3-C3aR signaling influences the neuronal transcriptome might also reveal more mechanistic insight into how this pathway modulates tau pathology.”
BackgroundInfluentialMicroglia in neuropathology caused by protozoan parasites
Figarella, K., Wolburg, H., Garaschuk, O., & Duszenko, M. (2019) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12566 · Cited by 14
“Detection of a parasite by the host immune system outside the brain thus likely triggers a microglial reaction, as has been shown for peripheral injection of the bacterial cell wall component lipopolysaccharide (LPS) (Cunningham, 2013; Hoogland et al., 2015).”
BackgroundMega-Analysis of Gene Expression in Mouse Models of Alzheimer’s Disease
Zhuang, B. C., Mancarci, B. O., Toker, L., & Pavlidis, P. (2019) · eNeuro · doi:10.1523/eneuro.0226-19.2019 · Cited by 15
Paasila, P. J., Davies, D., Sutherland, G. T., & Goldsbury, C. S. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-2845 · Cited by 25
How Microglia Manages Non-cell Autonomous Vicious Cycling of Aβ Toxicity in the Pathogenesis of AD
Seol, Y., Ki, S., Ryu, H. L., Chung, S., Lee, J.-H., & Ryu, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.593724 · Cited by 15
“Aβ also activates the complement cascade by directly binding to C1q, contributing to the upregulation of C3 which is recognized by microglial complement receptor (CR3) and triggering microglial engulfment of the synapse (Hong et al., 2016; Cardozo et al., 2019; Hemonnot et al., 2019).”
BackgroundSchnöder, L., Tomic, I., Schwindt, L., Helm, D., Rettel, M., Schulz‐Schaeffer, W., Krause, E., Rettig, J., Fassbender, K. C., & Liu, Y. (2021) · The FASEB Journal · doi:10.1096/fj.202100017r · Cited by 12
Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model
Verheijen, B. M., Stevens, J., Gentier, R. J. G., Hekke, C. D. V. ‘., van den Hove, D., Hermes, D. J. H. P., Steinbusch, H. W. M., Ruijter, J. M., Grimm, M. O. W., Haupenthal, V. J., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.011 · Cited by 14
A decade of diverse microglial-neuronal physical interactions in the brain (2008–2018)
Uweru, J. O., & Eyo, U. B. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.001 · Cited by 14
Genetic variability in response to Aβ deposition influences Alzheimer’s risk
Salih, D. A., Bayram, S., Guelfi, M. S., Reynolds, R., Shoai, M., Ryten, M., Brenton, J., Zhang, D., Matarin, M., Botia, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/437657 · Cited by 12
Control of microglial dynamics by Arp2/3 and the autism and schizophrenia-associated protein Cyfip1
Drew, J., Arancibia-Carcamo, I. L., Jolivet, R., Lopez-Domenech, G., Attwell, D., & Kittler, J. T. (2020) · doi:10.1101/2020.05.31.124941 · Cited by 12
Astrocytic synapse elimination controls ocular dominance plasticityPreprint
Lee, J.-H., Kim, J., Kim, M., Shin, C.-H., & Chung, W. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.23.509193 · Cited by 14
Zablotska, L. B., Župunski, L., Leuraud, K., Lopes, J., Hinkle, J. J., Pugeda, T., Delgado, T., Olschowka, J. A., Williams, J. P., O’Banion, M. K., et al. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2023.2142984 · Cited by 15
Multiple Sclerosis and Other Acquired Demyelinating Diseases of the Central Nervous System
Kornberg, M. D., & Calabresi, P. A. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041374 · Cited by 18
Microglial phagocytosis in epilepsy: Mechanisms and impact
Barath, A. S., & Wu, L. (2025) · The Journal of Physiology · doi:10.1113/jp288573 · Cited by 18
“However, excessive synaptic pruning such as that observed with loss of PRC2, an epigenetic regulator of phagocytosis (Ayata et al., 2018), or with increased levels of C1q or C3 deposition in adult brain (Gomez-Arboledas et al., 2021; Hong et al., 2016) can also predispose to increased seizures (Fig.”
Kang, X., Tian, J., Shu, Q., Cheng, T., Wang, S., & Hu, Y. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.07.019 · Cited by 12
“This activates the classical complement cascade via the C1q-C3-complement receptor 3 (CR3) axis, triggering excessive microglial phagocytosis of complement-labeled synapses through CR3 and ultimately causing synapse loss (Hong et al., 2016).”
Mackey-Alfonso, S. E., & Barrientos, R. M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70911 · Cited by 15
“250,274 A β oligomers, rather than insoluble fibrillar A β , appear to be more strongly linked to synaptic toxicity.”
InfluentialLawrence, J. M., Dampier, W., Mell, J. C., Souza, D. R. D., Schardien, K. A., Yeakle, K., Barnett, R. J., Sen, B., Ahmed, A., Bouchard, M. J., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05409-z · Cited by 14
“Upregulation of C3 and other complement cascade genes by neurotoxic astrocytes can result in inflammation, synaptic damage, and neuronal excitotoxicity [10, 19, 20].”
Farzinpour, Z., Liu, A., Cao, P., Mao, Y., Zhang, Z., & Jin, Y. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.898346 · Cited by 12
Li, Z., Wong, L. R., Wong, P., Shen, W. X., Yang, S., Huang, L., Lim, Y.-A., & Ho, P. C. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100599 · Cited by 14
Balbi, M., Bonanno, G., Bonifacino, T., & Milanese, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065240 · Cited by 14
“Accordingly, inhibiting C1q or blocking the microglial complement receptor CR3 reduced the microglia-operated synapse phagocytosis and synaptic loss in the early stage of the disease [223].”
BackgroundhiPSC-derived GRN-deficient astrocytes delay spiking activity of developing neurons
Lee, C., Frew, J., Weilinger, N. L., Wendt, S., Cai, W., Sorrentino, S., Wu, X., MacVicar, B. A., Willerth, S. M., & Nygaard, H. B. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106124 · Cited by 11
“Pruning depends on synaptic activity [25], and is implicated as a maladaptive and pathogenic process in models of both FTD-GRN and AD [26, 27].”
BackgroundGagnon, M., Savard, M., Tran, T. M. H., Vincent, L., Moquin, A., Tremblay, P., Roucou, X., Dory, Y. L., & Gobeil, F. (2023) · Molecules · doi:10.3390/molecules28135206 · Cited by 15
Castro, R. W., Lopes, M. C., Biase, L. M. D., & Valdez, G. (2023) · Glia · doi:10.1002/glia.24470 · Cited by 11
“…of developmental synaptic pruning mechanisms, such as the complement system, could be responsible for synaptic degeneration in aging and diseases such as Alzheimer's disease, autism spectrum disorder, and schizophrenia (Hong et al., 2016; Presumey et al., 2017; Rajendran & Paolicelli, 2018).”
BackgroundXing, Y., Zhang, D., Fang, L., Wang, J., Liu, C., Wu, D., Yu, Y., Zhang, T., Wang, X., & Min, W. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103244 · Cited by 12
Cao, Q., Kumar, M., Frazier, A., Williams, J. B., Zhao, S., & Yan, Z. (2023) · Aging · doi:10.18632/aging.205057 · Cited by 13
Intermittent hypoxia: linkage between OSAS and epilepsy
Ma, Y., & Wu, Q. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1230313 · Cited by 12
Efficacy of exercise rehabilitation for managing patients with Alzheimer’s disease
Li, D., Jia, J., Zeng, H., Zhong, X., Chen, H., & Yi, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.391308 · Cited by 16
Radiotherapy for non-cancer diseases: benefits and long-term risks
Thariat, J., Little, M. P., Zablotska, L. B., Samson, P. P., O’Banion, M. K., Leuraud, K., Bergom, C. R., Girault, G., Azimzadeh, O., Bouffler, S. D., et al. (2024) · International Journal of Radiation Biology · doi:10.1080/09553002.2023.2295966 · Cited by 15
“Synaptic loss in AD and aging depends in part on complement activation and direct pruning by complement receptor bearing microglia (Shi et al. 2015, 2017; Hong et al. 2016).”
BackgroundXing, Y., Shi, H., Gao, X., Zhu, X., Zhang, D., Fang, L., Wang, J., Liu, C., Wu, D., Wang, X., et al. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c01201 · Cited by 12
Associations of amyloid-β oligomers and plaques with neuropathology in the AppNL-G-F mouse
Tang, J., Huang, H. X., Muirhead, R. C. J., Zhou, Y., Li, J., DeFelice, J., Kopanitsa, M. V., Serneels, L., Davey, K., Tilley, B. S., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae218 · Cited by 12
“15 This could promote synaptic loss in Alzheimer’s disease.”
BackgroundYang, M., Zhu, H., Peng, L., Yin, T., Sun, S., Du, Y., Li, J., Liu, J., & Wang, S. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114906 · Cited by 11
“Dendritic complexity is closely associated with synaptic pruning via microglial pruning mediated by the complement system, associated closely with abnormal behavior(Chung et al., 2023; Hong et al., 2016; Werneburg et al., 2020).”
BackgroundC9orf72 dipeptides activate the NLRP3 inflammasome
Rivers‐Auty, J., Hoyle, C., Pointer, A., Lawrence, C. B., Pickering-Brown, S. M., Brough, D., & Ryan, S. (2024) · Brain Communications · doi:10.1093/braincomms/fcae282 · Cited by 15
“19,20 Despite the potential importance of neuroinflammation to disease pathogenesis, the causes of immune cell activation and inflammation in C9FTD/ALS are unknown.”
BackgroundThe future of complement therapeutics
Kolev, M. V., Rao, K. N., Yeh, M. W., Parikh, A., & Deschatelets, P. (2024) · Exploration of Immunology · doi:10.37349/ei.2024.00161 · Cited by 15
Immune system activation and cognitive impairment in arterial hypertension
Schreiber, S., Arndt, P., Morton, L., Garza, A. P., Müller, P., Neumann, K., Mattern, H., Dörner, M., Bernal, J., Vielhaber, S., et al. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00219.2024 · Cited by 15
Gao, Q.-C., Liu, G.-L., Wang, Q., Zhang, S., Ji, Z., Wang, Z., Wu, M., Yu, Q., & He, P. F. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103420 · Cited by 12
Li, L.-J., Liang, S., Sun, X., Zhu, J., Niu, X.-Y., Du, X.-Y., Huang, Y., & Liu, R. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03333-6 · Cited by 15
“Microglia have also been shown to excessively uptake synapses in a C3-dependent manner in AD models [43–46].”
Xu, Y., Shao, N., Zhi, F., Chen, R., Yang, Y., Li, J., Xia, Y., & Peng, Y. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01682-1 · Cited by 16
Zhang, Y., Kong, Q., Fan, J., & Zhao, H. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107658 · Cited by 15
Pokrzyk, J., Kulczyńska‐Przybik, A., Guzik-Makaruk, E. M., Winkel, I., & Mroczko, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051935 · Cited by 16
“[10,11] Proteins involved in the inflammatory response, such as cytokines (e.g., interleukin-1 β , tumor necrosis factor-α ), chemokines and complement proteins, are upregulated in AD brains and contribute to disease progression.”
Liberto, G. D., Égervári, K., Vogrig, A., Spatola, M., Piccinno, M., Vincenti, I., Wagner, I., Kreutzfeldt, M., Endmayr, V., Ostertag, K., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02882-7 · Cited by 14
“Specifically, the complement protein C3 has been found to tag synapses for elimination via C3 receptor (CR3)-mediated phagocytosis [41] during visual system development [46] but also viral encephalitis [53], Alzheimer’s disease [24] and demyelinating diseases [57].”
Lesgards, J., Cerdan, D., & Perronne, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167879 · Cited by 15
“Moreover, microglial activation and complement sys-tem activation share pathological mechanisms in various neurodegenerative disorders, including Alzheimer’s disease [248–250].”
Complement C3a: Shaping the Plasticity of the Post-stroke Brain
Stokowska, A., & Pekna, M. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-66679-2_26 · Cited by 14
Xu, J., Zhang, Z., Liu, R., Sun, Y. X., Liu, H., Nie, Z., Zhao, X., & Pu, X. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.002 · Cited by 11
Spatiotemporal Control of Neuronal Remodeling by Cell Adhesion Molecules: Insights From Drosophila
Meltzer, H., & Schuldiner, O. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.897706 · Cited by 12
Microglia in Alzheimer’s Disease: A Favorable Cellular Target to Ameliorate Alzheimer’s Pathogenesis
Sumsuzzman, D. M., Uddin, M. S., Kabir, M. T., Hasana, S., Perveen, A., Alanazi, I. S., Albadrani, G. M., Abdel‐Daim, M. M., & Ashraf, G. M. (2022) · Mediators of Inflammation · doi:10.1155/2022/6052932 · Cited by 12
“Furthermore, a study in AD mice showed that microglia were associated with synaptic pruning in a CR3-dependent pathway [93].”
BackgroundTomizawa, I., Nakagawa, H., Sohma, Y., Kanai, M., Hori, Y., & Tomita, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.945017 · Cited by 11
Hua, J., Wang, F., Wei, X., Qin, Y., Lian, J., Wu, J., Ma, P., & Ma, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054317 · Cited by 11
“It wa reported recently that the misfolding Aβ aggregates can cause synaptic toxicity, inducing the injury and dysfunction of neuronal synapses [53].”
BackgroundVar, S. R., Strell, P., Johnson, S. T., Roman, A., Vasilakos, Z., & Low, W. C. (2023) · Cell Transplantation · doi:10.1177/09636897231171001 · Cited by 15
Alzheimer’s Disease and Its Possible Evolutionary Origin: Hypothesis
Whitfield, J. F., Rennie, K., & Chakravarthy, B. (2023) · Cells · doi:10.3390/cells12121618 · Cited by 12
Jin, B., Cheng, X., Fei, G., Sang, S., & Zhong, C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1169620 · Cited by 12
“…the best with cognitive impairment and even precedes neuronal loss in AD, and there are many factors contributing to synaptic dysfunction in AD, especially the above-identified: immune response and oxidative stress (DeKosky and Scheff, 1990; Britschgi and Wyss-Coray, 2007; Hong et al., 2016).”
BackgroundInfluentialYin, P., Cai, Y., Cui, T., Berg, A. J., Wang, T., Morency, D. T., Paganelli, P. M., Lok, C., Yang, X., Vicini, S., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0515-23.2023 · Cited by 11
Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms
Xu, Z., Wang, H., Jiang, S., Teng, J., Zhou, D., Chen, Z., Wen, C., & Xu, Z. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01110-0 · Cited by 10
“Elevated complements like C1q and C3, combined with microglia, are linked to the synaptic loss and toxicity of soluble β-amyloid (Aβ) oligomers [139].”
Petrisko, T. J., Gargus, M. D., Chu, S., Selvan, P., Whiteson, K., & Tenner, A. J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02885-9 · Cited by 12
“In the AD brain, complement components including C1q, C3, and C4 co-localize with fibrillar amyloid plaques and C1q and C3 fragments tag synapses promoting engulfment by microglia [5].”
BackgroundLoss of maturity and homeostatic functions in Tuberous Sclerosis Complex-derived astrocytes
Luinenburg, M. J., Scheper, M., Sørensen, F. N. F., Anink, J. J., Hecke, W. V., Korshunova, I., Jansen, F. E., Riney, K., van Eijsden, P., Gosselaar, P. H., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1284394 · Cited by 12
Therapeutic Potentials of Synapses after Traumatic Brain Injury: A Comprehensive Review
Wen, Z., Li, D., Shen, M., & Chen, G. (2017) · Neural Plasticity · doi:10.1155/2017/4296075 · Cited by 14
“The microglia offers a beneficial hand to neuronal circuit formation via phagocytosing weak synapses and regulating neurogenesis [42], but excessive microglia accumulations may cause serious impairments to the synaptic pruning and disrupt the synaptic plasticity [43, 44].”
BackgroundBurns, M. E., & Stevens, B. (2018) · eNeuro · doi:10.1523/eneuro.0035-18.2018 · Cited by 11
“Conversely, inappropriate activation of microglia mediates loss of synapses in a mouse model of Alzheimer’s disease (Hong et al., 2016) and related diseases (Lui et al.”
BackgroundSelf-citationA Double‐Edged Sword: Complement Component 3 in Toxoplasma gondii Infection
Huang, W., Wang, Y., Mahmmod, Y. S., Wang, J., Liu, T., Yu-Xiang, Z., Zhou, X., Zhang, X., & Yuan, Z. (2018) · PROTEOMICS · doi:10.1002/pmic.201800271 · Cited by 11
Myeloid cells in the central nervous system: So similar, yet so different
Quintana, F. J. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw2841 · Cited by 12
“For example, microglia-driven synapse pruning plays an important role in CNS development but may also be an active player in neurologic disorders (1).”
Background
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.